Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.

TEVA

Teva Pharmaceutical Indu... (TEVA)

Teva Pharmaceutical Industries Ltd
De:
Trier par:
 Showing the most relevant articles for your search:NYSE:TEVA
DateHeureSourceTitreSymboleSociété
22/04/201503h46Dow Jones NewsTeva Offers to Buy Mylan for $40 Billion -- 5th UpdateNYSE:TEVATeva Pharmaceutical Industries Ltd
21/04/201523h23Edgar (US Regulatory)Report of Foreign Issuer (6-k)NYSE:TEVATeva Pharmaceutical Industries Ltd
21/04/201523h14Dow Jones NewsU.S. Stocks Fall on Mixed EarningsNYSE:TEVATeva Pharmaceutical Industries Ltd
21/04/201522h58Dow Jones NewsMARKET SNAPSHOT: U.S. Stocks Close Mostly Lower After Barrage Of EarningsNYSE:TEVATeva Pharmaceutical Industries Ltd
21/04/201521h42The Motley FoolWhy Mylan NV Is Suddenly in the Driver's SeatNYSE:TEVATeva Pharmaceutical Industries Ltd
21/04/201521h03Dow Jones NewsTeva's Deal for Mylan Shows Corporate Israel's M&A HungerNYSE:TEVATeva Pharmaceutical Industries Ltd
21/04/201518h36Dow Jones NewsMARKET SNAPSHOT: S&P 500, Dow Erase Gains After Barrage Of EarningsNYSE:TEVATeva Pharmaceutical Industries Ltd.
21/04/201516h30Dow Jones NewsTeva Offers to Buy Mylan for $40 Billion -- 4th UpdateNYSE:TEVATeva Pharmaceutical Industries Ltd.
21/04/201516h20Dow Jones NewsMARKET SNAPSHOT: U.S. Stocks Mixed After Earnings, Merger NewsNYSE:TEVATeva Pharmaceutical Industries Ltd.
21/04/201516h09Dow Jones NewsTeva Offers to Buy Mylan for $40 Billion -- 3rd UpdateNYSE:TEVATeva Pharmaceutical Industries Ltd.
21/04/201515h49Dow Jones NewsTeva Offers to Buy Mylan for $40 Billion -- 2nd UpdateNYSE:TEVATeva Pharmaceutical Industries Ltd
21/04/201515h40Dow Jones NewsTeva Offers to Buy MylanNYSE:TEVATeva Pharmaceutical Industries Ltd.
21/04/201515h39Dow Jones NewsTeva Offers to Buy Mylan for $40 Billion -- UpdateNYSE:TEVATeva Pharmaceutical Industries Ltd
21/04/201515h26Dow Jones NewsTeva Offers to Buy Mylan For $82 A ShareNYSE:TEVATeva Pharmaceutical Industries Ltd
21/04/201515h16Analyst Ratings NetworkTeva Pharmaceutical Industries Rating Lowered to Market Perform at BMO Capital Markets (TEVA)NYSE:TEVATeva Pharmaceutical Industries Ltd
21/04/201514h45Business WireTeva Proposes to Acquire Mylan for $82.00 Per Share in Cash and StockNYSE:TEVATeva Pharmaceutical Industries Ltd
21/04/201502h34Dow Jones NewsADR Shares End Mixed; Teva, Carnival DeclineNYSE:TEVATeva Pharmaceutical Industries Ltd
18/04/201518h03The Motley Fool3 Top Healthcare Stocks Surging Higher This YearNYSE:TEVATeva Pharmaceutical Industries Ltd
17/04/201521h30Dow Jones NewsTeva Pharmaceutical Considering Bid for MylanNYSE:TEVATeva Pharmaceutical Industries Ltd.
17/04/201521h29Dow Jones NewsTeva Pharmaceutical Considering Bid for Mylan -- UpdateNYSE:TEVATeva Pharmaceutical Industries Ltd
17/04/201514h00Business WireTeva to Report First Quarter 2015 Financial Results on April 30, 2015NYSE:TEVATeva Pharmaceutical Industries Ltd
16/04/201523h15The Motley FoolWhy Momenta Pharmaceuticals Inc. Shares Are Surging HigherNYSE:TEVATeva Pharmaceutical Industries Ltd
16/04/201522h51Dow Jones NewsFDA Approves Generic Multiple-Sclerosis Drug by Novartis's Sandoz and Momenta -- UpdateNYSE:TEVATeva Pharmaceutical Industries Ltd.
16/04/201522h07Dow Jones NewsFDA Approves Novartis and Momenta's Generic Multiple-Sclerosis DrugNYSE:TEVATeva Pharmaceutical Industries Ltd.
14/04/201514h00Business WireTeva and Eagle Pharmaceuticals Announce NDA for Bendamustine Rapid Infusion Product Accepted for FilingNYSE:TEVATeva Pharmaceutical Industries Ltd
13/04/201514h00Business WireTeva to Present Multiple Sclerosis Data at 67th American Academy of Neurology (AAN) Annual Meeting in Washington, D.C.NYSE:TEVATeva Pharmaceutical Industries Ltd
03/04/201523h30PR Newswire (US)SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Announces the Investigation of Auspex Pharmaceuticals, Inc. Over the Proposed Sale of...NYSE:TEVATeva Pharmaceutical Industries Ltd
03/04/201517h37PR Newswire (US)WeissLaw LLP: The Auspex Pharmaceuticals, Inc. Acquisition by Teva Pharmaceutical Industries Is the Subject of a Legal Invest...NYSE:TEVATeva Pharmaceutical Industries Ltd
02/04/201514h00GlobeNewswire Inc.Teva and Xenon Announce Enrollment of First Patient in a Phase 2b Study Evaluating TV-45070 for Postherpetic Neuralgia (PHN)NYSE:TEVATeva Pharmaceutical Industries Ltd
01/04/201514h00Business WireTeva Announces FDA Approval of ProAir® RespiClickNYSE:TEVATeva Pharmaceutical Industries Ltd
 Showing the most relevant articles for your search:NYSE:TEVA